We are live on ! Find out more
ASPX

AUSPEX PHARMACEUTICALS INC COM STK (DE)
ASPX

Delisted

ASPX was delisted on the 4th of May, 2015.

Back to rankings

138 hedge funds and large institutions have $1.91B invested in AUSPEX PHARMACEUTICALS INC COM STK (DE) in 2015 Q1 according to their latest regulatory filings, with 70 funds opening new positions, 41 increasing their positions, 20 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

704% more call options, than puts

Call options by funds: $14.8M | Put options by funds: $1.85M

233% more first-time investments, than exits

New positions opened: 70 | Existing positions closed: 21

147% more capital invested

Capital invested by funds: $773M → $1.91B (+$1.14B)

105% more repeat investments, than reductions

Existing positions increased: 41 | Existing positions reduced: 20

80% more funds holding in top 10

Funds holding in top 10: 5 → 9 (+4)

55% more funds holding

Funds holding: 89 → 138 (+49)

Holders
138
Holders Change
+49
Holders Change %
+55.06%
% of All Funds
3.68%
Holding in Top 10
9
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+80%
% of All Funds
0.24%
New
70
Increased
41
Reduced
20
Closed
21
Calls
$14.8M
Puts
$1.85M
Net Calls
+$13M
Net Calls Change
+$13M

Top Buyers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
+$99.9M
2
JHIU
Janus Henderson Investors US
Colorado
+$41.7M
3
AAM
Alpine Associates Management
Florida
+$38.8M
4
WIC
Water Island Capital
New York
+$33.9M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$30M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$152M
2
Jennison Associates
Jennison Associates
New York
-$29.4M
3
KCM
Kingdon Capital Management
New York
-$21.1M
4
Bank of Montreal
Bank of Montreal
Ontario, Canada
-$20M
5
Bank of New York Mellon
Bank of New York Mellon
New York
-$7.98M
Name Holding Trade Value Shares
Change 		Change in
Stake
Charles Schwab
51
Charles Schwab
California
$4.34M +$1.28M +19,269 +80%
Morgan Stanley
52
Morgan Stanley
New York
$4.26M +$1.6M +24,093 +131%
GCIA
53
Gabelli & Co Investment Advisers
New York
$4.25M +$2.82M +42,399 New
GI
54
GAMCO Investors
Connecticut
$3.75M +$2.49M +37,450 New
CS
55
Candriam SCA
Luxembourg
$3.61M +$2.4M +36,000 New
BIM
56
BlackRock Investment Management
Delaware
$3.04M +$222K +3,337 +12%
Allianz Asset Management
57
Allianz Asset Management
Germany
$2.94M +$1.95M +29,300 New
Invesco
58
Invesco
Georgia
$2.77M +$434K +6,513 +31%
ProShare Advisors
59
ProShare Advisors
Maryland
$2.68M +$430K +6,450 +32%
CCM
60
Century Capital Management
Massachusetts
$2.57M +$1.71M +25,598 New
CS
61
Credit Suisse
Switzerland
$2.56M -$392K -5,883 -19%
AIMCA
62
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
$2.51M +$1.67M +25,000 New
BBA
63
Baker Bros. Advisors
New York
$2.51M +$1.67M +25,000 New
Point72 Asset Management
64
Point72 Asset Management
Connecticut
$2.46M +$1.63M +24,500 New
AQR Capital Management
65
AQR Capital Management
Connecticut
$2.31M +$1.53M +23,000 New
CSS
66
Cubist Systematic Strategies
Connecticut
$2.17M +$1.44M +21,666 New
Swiss National Bank
67
Swiss National Bank
Switzerland
$2.11M +$626K +9,400 +81%
SKK
68
Shepherd Kaplan Krochuk
Massachusetts
$1.98M -$557K -8,363 -30%
VIA
69
Vident Investment Advisory
Georgia
$1.98M +$1.32M +19,790 New
BA
70
BlackRock Advisors
Delaware
$1.97M +$956K +14,347 +271%
California State Teachers Retirement System (CalSTRS)
71
California State Teachers Retirement System (CalSTRS)
California
$1.9M +$113K +1,700 +10%
Goldman Sachs
72
Goldman Sachs
New York
$1.88M +$939K +14,092 +300%
PCM
73
Prelude Capital Management
New York
$1.77M +$1.18M +17,691 New
TA
74
Teachers Advisors
New York
$1.58M +$213K +3,194 +25%
CWG
75
C WorldWide Group
Denmark
$1.55M -$5.49M -82,421 -84%
1 2
3
4 5

ASPX Hedge Fund Activity: Q1 2015 in Review

138 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in AUSPEX PHARMACEUTICALS INC COM STK (DE) (ASPX) for Q1 2015, worth a combined $1.91B — up 147% from $773M a quarter earlier.

Buyers outnumbered sellers: 70 funds opened new ASPX positions and 21 closed out — a net gain of 49 holders — while 41 added to existing stakes and 20 trimmed.

The largest buyer was Deerfield Management, adding an estimated $99.9M. The largest seller was Fidelity Investments, cutting an estimated $152M.

  • 138 institutional investors held AUSPEX PHARMACEUTICALS INC COM STK (DE) (ASPX) as of Q1 2015, up from 89 in Q4 2014.
  • Funds reported $1.91B of AUSPEX PHARMACEUTICALS INC COM STK (DE) stock for Q1 2015, up 147% quarter-over-quarter.
  • 70 funds opened new AUSPEX PHARMACEUTICALS INC COM STK (DE) positions in Q1 2015 and 21 closed out, a net change of +49 holders.
  • The largest AUSPEX PHARMACEUTICALS INC COM STK (DE) buyer in Q1 2015 was Deerfield Management, an estimated $99.9M added.
  • The largest AUSPEX PHARMACEUTICALS INC COM STK (DE) seller in Q1 2015 was Fidelity Investments, an estimated $152M sold.

Based on aggregated 13F filings for Q1 2015.